(Q38433368)

English

Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.

scientific article published on 21 April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Stephen E Borst

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Joshua F Yarrow

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

21 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

308

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

E1035-42

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Testosterone treatment of men with alcoholic cirrhosis: A double-blind study

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Trends in androgen prescribing in the United States, 2001 to 2011.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Adverse events associated with testosterone administration

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Age-related prevalence of low testosterone in men with spinal cord injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Influence of aromatase inhibition on the bone-protective effects of testosterone.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone administration induces protection against global myocardial ischemia

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone administration to older men improves muscle function: molecular and physiological mechanisms

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Global trends in testosterone prescribing, 2000-2011: expanding the spectrum of prescription drug misuse

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Androgen actions on the human hair follicle: perspectives

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

The decline of androgen levels in elderly men and its clinical and therapeutic implications

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Osteoporosis in older men: recent advances in pathophysiology and treatment.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Aneurysm of coronary-pulmonary artery fistula diagnosed non-invasively by contrast echocardiography and multi-detector computed tomography

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Androgen treatment of abdominally obese men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

17β-Hydroxyestra-4,9,11-trien-3-one (Trenbolone) preserves bone mineral density in skeletally mature orchiectomized rats without prostate enlargement.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

DHEA in elderly women and DHEA or testosterone in elderly men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Androgen effects on skeletal muscle: implications for the development and management of frailty

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Androgen treatment and muscle strength in elderly men: A meta-analysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone metabolites mediate its effects on myocardial damage induced by ischemia/reperfusion in male Wistar rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

A randomized pilot study of monthly cycled testosterone replacement or continuous testosterone replacement versus placebo in older men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

An integrative review on current evidence of testosterone replacement therapy for the andropause

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Long-term survival of participants in the prostate cancer prevention trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone supplementation in heart failure: a meta-analysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Periodized resistance training with and without supplementation improve body composition and performance in older men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone-induced hypertrophy of L6 myoblasts is dependent upon Erk and mTOR.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Intracrine and myotrophic roles of 5α-reductase and androgens: a review

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Testosterone and Adult Male Bone: Actions Independent of 5α-Reductase and Aromatase

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

On model selections for repeated measurement data in clinical studies

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Antiandrogenic therapy with finasteride attenuates cardiac hypertrophy and left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Bone benefits of testosterone replacement therapy in male hypogonadism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6189635

5 November 2018

Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6189635

5 November 2018

Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6189635

5 November 2018

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6189635

5 November 2018

A critical evaluation of simple methods for the estimation of free testosterone in serum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6189635

5 November 2018

Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6189635

5 November 2018

Testosterone Gel Combined with Depomedroxyprogesterone Acetate Is an Effective Male Hormonal Contraceptive Regimen and Is Not Enhanced by the Addition of a GnRH Antagonist

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00111.2015

21 January 2018

Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/25898953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men

1 reference

https://pubmed.ncbi.nlm.nih.gov/25898953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anabolic effects of testosterone are preserved during inhibition of 5alpha-reductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/25898953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of testosterone therapy in males with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25898953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated bone loss and increased post-fracture mortality in elderly women and men

1 reference

https://pubmed.ncbi.nlm.nih.gov/25898953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testosterone treatment of men with alcoholic cirrhosis: a double-blind study. The Copenhagen Study Group for Liver Diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25898953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of 5alpha-reductase inhibition with finasteride and dutasteride on bone mineral density in older men with benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25898953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1152/AJPENDO.00111.2015

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38433368&oldid=2093281438"